Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.4%

1 terminated/withdrawn out of 72 trials

Success Rate

98.0%

+11.5% vs industry average

Late-Stage Pipeline

4%

3 trials in Phase 3/4

Results Transparency

6%

3 of 49 completed trials have results

Key Signals

15 recruiting3 with results

Enrollment Performance

Analytics

N/A
31(59.6%)
Phase 1
15(28.8%)
Phase 2
3(5.8%)
Phase 4
2(3.8%)
Phase 3
1(1.9%)
52Total
N/A(31)
Phase 1(15)
Phase 2(3)
Phase 4(2)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (72)

Showing 20 of 72 trials
NCT05770349Recruiting

Ultrastructural Characteristics of Mitochondria in Cardiomyocytes in Heart Failure

Role: lead

NCT07476274Recruiting

Nosocomial Pneumonia After Coronary Artery Bypass Grafting

Role: lead

NCT07487714Phase 4Enrolling By Invitation

Comparative Efficacy of 100-, 200-, & 400-mg Amiodarone in Patients With Paroxysmal AF Depending on Plasma Concentration

Role: lead

NCT07480915Recruiting

Risk Stratification of MACE in Heart Failure Patients Who Undergoing CABG

Role: lead

NCT07475390Not ApplicableActive Not Recruiting

99mTc-1-thio-D-glucose SPECT/CT Versus 18F-Fluoroethyl-l-tyrosine PET/CT in Brain Tumor Imaging

Role: lead

NCT05336565Recruiting

PIM Incidence in Older Cardiovascular Patients During COVID-19 Pandemics

Role: lead

NCT07457541Phase 1Active Not Recruiting

Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPI

Role: lead

NCT07018895Not ApplicableCompleted

Personalized Hypoxic-hyperoxic Preconditioning in Elderly People

Role: lead

NCT06159699Recruiting

Telecommunication Technology-based Online Survey

Role: lead

NCT07275463Phase 2Enrolling By Invitation

[99mTc]Tc-DB8 Accumulation in Primary Tumor in Breast Cancer With Positive and Negative Estrogen Receptor Expression

Role: lead

NCT07292571Phase 2Enrolling By Invitation

Evaluation of Different Types of HER2 Expression in Breast Cancer Using [99mTc]Tc -ZHER2:4107

Role: lead

NCT05793996Phase 4Recruiting

The Prevalence of Iron Deficiency and the Effectiveness of Ferinject® in Patients With HFpEF (ID-HFpEF)

Role: lead

NCT06567249Not ApplicableRecruiting

Intracoronary Hypothermia as a Prevention of Reperfusion Injury in Myocardial Infarction.

Role: lead

NCT06759259Completed

Mannitol Administration for Delerium Prevention

Role: lead

NCT06261827Not ApplicableCompleted

High-dose Inhaled NO Therapy for the pREvenvention of NP After Cardiac Surgery Under CPB

Role: lead

NCT06969547Recruiting

Mechanical Dyssynchrony and Microvascular Dysfunction by SPECT

Role: lead

NCT05769036Not ApplicableRecruiting

Conventional Biventricular Versus Left Bundle Branch Pacing on Outcomes in Heart Failure Patients

Role: lead

NCT05757557Phase 1Completed

Perioperative Nitric Oxide Prevents Acute Kidney Injury in Cardiac Surgery Patients With Chronic Kidney Disease

Role: lead

NCT06170372Not ApplicableRecruiting

High-dose Inhalations of Nitric Oxide in the Treatment of Pneumonia

Role: lead

NCT05923177Phase 1Completed

Molecular Imaging of HER2 Expression in Breast Cancer Using [123I] I-(HE)3-G3

Role: lead